BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Cancer Epigenetics Society - ECPv5.3.2.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Cancer Epigenetics Society
X-ORIGINAL-URL:https://ces.b2sg.org
X-WR-CALDESC:Events for Cancer Epigenetics Society
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20191027T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190131
DTEND;VALUE=DATE:20190305
DTSTAMP:20260729T212950
CREATED:20190131T141734Z
LAST-MODIFIED:20190131T141923Z
UID:21047-1548892800-1551743999@ces.b2sg.org
SUMMARY:Postdoctoral Fellow
DESCRIPTION:We are seeking a driven and accomplished postdoctoral fellow to join the Cancer Immunology Discovery (CID) group within the Oncology R&D (WRD) unit of Pfizer. \nThe successful candidate with lead a research project to understand how epigenetic mechanisms control the anti-tumor immune response\, and to translate the findings into better therapies with curative potential for cancer patients. \nThe project builds on promising preliminary data and applies cutting-edge technologies to address what is to date a major scientific question with great clinical implications. Guided by experienced mentors with strong academic track records\, the successful candidate will study fundamental questions in cancer immunology with the goal of publishing in high-impact journals. The postdoc will also interact extensively with leading scientists in small and large molecule drug discovery\, collaborate with computational\, early clinical\, and translational oncology colleagues across Pfizer\, present in internal and external conferences\, and receive mentorship to become a prolific independent scientific investigator. \nROLE RESPONSIBILITIES \nThe successful candidate will work independently\, but with guidance by experienced mentors\, to: \n\nDiscover the novel mechanisms through which epigenetic enzymes regulate T cell activation\, differentiation\, trafficking and exhaustion\, in combination with I-O agents.\nDesign and perform studies to evaluate the anatomical distribution\, persistence and function of antigen-specific T cells in preclinical models of cancer.\nCollaborate with teams in tumor biology\, protein engineering\, computational biology\, clinical development to discover novel biology and as a result identify better treatments for cancer patients.\nPresent at group meetings\, internal and external conferences\, and publish in high impact journals.\nContribute to building a culture that embraces scientific excellence\, integrity\, effectiveness\, humility\, continuous learning and team work.\n\nBASIC QUALIFICATIONS \n\nPh.D. in Immuno-oncology\, Immunology\, Cancer Biology or a comparable biological science\, with a strong track record of scientific publications.\n0-4 years of postdoctoral experience.\nSolid hands-on experience with conventional immunological techniques: immune cell isolation\, multi-color flow cytometry\, in vitro immune cell functional assays and in vivo tumor models.\nExperience in assessing T cell function\, differentiation\, exhaustion and memory development.\nMust have excellent organization and planning skills\, the ability to work in a fast-paced environment independently and as part of a team. Excellent verbal and written communication\, and strong motivation with a dedicated work ethic.\nAble to master new concepts and techniques quickly.\n\nPREFERRED QUALIFICATIONS \n\n2+ years research experience in T cell biology and/or epigenetics.\nStrong understanding of innate and adoptive immune systems.\nPrior experience or a strong interest in developing novel immunotherapies for cancer.\nHands-on experience in qRT-PCR\, ELISA\, Western blotting\, ChIP-seq\, RNA-seq\, ATAC-seq and CyTOF is desirable.\nHands-on experience in CRISPR\, RNAi\, lentiviral transduction and exogenous gene expression is a plus.\nHands-on experience in syngeneic and spontaneous tumor models\, adoptive cell transfer is desirable.
URL:https://ces.b2sg.org/event/pfi31jan19/
LOCATION:Pfizer – La Jolla\, CA\, 10350 N Torrey Pines Rd\, La Jolla\, CA\, 92037\, United States
CATEGORIES:Jobs
ATTACH;FMTTYPE=image/jpeg:https://ces.b2sg.org/wp-content/uploads/2018/05/pfizer_new_logo.jpg
END:VEVENT
END:VCALENDAR